Article
Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
Journal of clinical pathology - 1 May 2017
da Silva Fernanda Borges, Machado-Neto João Agostinho, Bertini Virginia Helena Leira Lipoli, Velloso Elvira Deolinda Rodrigues Pereira, Ratis Cristina Alonso, Calado Rodrigo T, Simões Belinda Pinto, Rego Eduardo Magalhães, Traina Fabiola
Abstract excerpt
AIMS: The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal haematopoietic stem cell disorders characterised by inefficient haematopoiesis and risk of progression to acute myeloid leukaemia. Metaphase cytogenetics is an extremely valuable clinical tool in the management of haematological malignancies. However, metaphase cytogenetics requires cellular proliferation, its sensitivity and resolution...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
